Assessment of Safety Profile of MVA-BN Vaccine in the PALM-007 Study in DRC
Clinical trial NCT05734508 · COMPLETED
Trial details
- NCT number
- NCT05734508
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-23
- Primary completion
- 2024-06-28
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.